- An analysis of published studies indicates that children with chronic kidney disease may have lower intellectual functioning compared than children in the general population.
- Compared with children with mild-to-moderate stage kidney disease and with kidney transplants, children on dialysis had the lowest IQ scores.
- Deficits were evident for attention, memory, and executive function domains.
Washington, DC (February 22, 2018) -- Children with chronic kidney disease (CKD) may have lower intellectual functioning compared with the general population, with mild deficits across academic skills, executive function, and visual and verbal memory. The findings, which appear in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN), come from an analysis of studies published through 2016.
CKD in children clearly affects their physical health, but research also indicates that it can have impacts on neurocognitive function, academic performance, and mental health. This can lead to long-term consequences for children with CKD as they transition into adulthood.
To look into this issue, Kerry Chen, MBBS (The Centre for Kidney Research, University of Sydney, in Australia) and her colleagues examined all of the published evidence on cognitive and academic outcomes in children and adolescents with CKD. Their analysis included 34 studies with more than 3000 CKD patients under the age of 21 years.
The analysis suggests that children with CKD may have low-average neurocognitive and academic outcomes. The global cognition IQ of children with CKD was classified as low-average. Compared with the general population, the average differences in IQ were -10.5 for all CKD stages, -9.39 for patients with mild-to-moderate stage CKD, -11.2 for patients who underwent kidney transplantation, and -16.2 for patients on dialysis. Direct comparisons showed that children with mild-to-moderate stage CKD and those who received kidney transplants scored 11.2 and 10.1 IQ points higher than children on dialysis. Children with CKD also had lower scores than the general population in executive function and memory domains, and they scored lower in tests of academic skills related to mathematics, reading, and spelling.
"In translating our findings to clinical practice, this research provides relevant information on the areas of need--for example, working memory and mathematics--for which children with CKD may need guidance, practice and assistance, particularly for children on dialysis," said Dr. Chen. "It also suggests hypotheses for why the overall intellectual and educational outcomes of children with CKD are reduced compared with the general population, and how best to prevent deficits."
An accompanying Patient Voice editorial provides the perspective of Lori Hartwell, Founder and President of the Renal Support Network, who has had kidney disease since 2 years of age. "I recall occasions while on hemodialysis experiencing poor cognition and difficulty retaining information," she wrote. "It is not surprising that children and adolescents on dialysis are at greater risk of such effects. Studies have shown a decline in cognitive function that has been associated with fluid and solute shifts while undergoing hemodialysis." She offers up a number of questions to consider as efforts are made to address patients' needs.
Study co-authors include Madeleine Didsbury, MD, Anita van Zwieten, MPH, Martin Howell, PhD, Siah Kim, PhD, Allison Tong, PhD, Kirsten Howard, PhD, Natasha Nassar, PhD, Belinda Barton, PhD, Suncica Lah, PhD, Jennifer Lorenzo, PhD, Giovanni Strippoli, PhD, Suetonia Palmer, PhD, Armando Teixeira-Pinto, PhD, Fiona Mackie, MBBS, Steven McTaggart, MBBS, Amanda Walker, MBBS, Tonya Kara, MBBS, Jonathan C. Craig, PhD, and Germaine Wong, PhD.
Disclosures: The authors reported no financial disclosures.
The article, entitled "Neurocognitive and Educational Outcomes in Children and Adolescents with Chronic Kidney Disease," will appear online at http://cjasn.
The editorial, entitled "Responsive Designed Interventions are Needed to Support Positive Outcomes of Children and Adolescents with Chronic Kidney Disease," will appear online at http://cjasn.
The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.
Since 1966, ASN has been leading the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients. ASN has nearly 18,000 members representing 112 countries. For more information, please visit http://www.